⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28619339 | 0.83 | DYRK1A (0.32) | — | |
| SCHEMBL27952254 | 0.77 | NCF1 (0.39) | — | |
| SCHEMBL11894063 | 0.77 | — | — | |
| SCHEMBL4492969 | 0.77 | — | — | |
| SCHEMBL3133642 | 0.77 | — | — | |
| SCHEMBL5985571 | 0.77 | — | — | |
| SCHEMBL7876670 | 0.77 | — | — | |
| SCHEMBL8944768 | 0.77 | — | — | |
| SCHEMBL19692379 | 0.77 | — | — | |
| SCHEMBL4726446 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| WO-2025038971-A1 | OLIGONUCLEOTIDES CONTAINING A LIGAND AT A NUCLEOBASE, 2' POSITION, OR 3' POSITION | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| EP-4508037-A1 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | The Chinese University of Hong Kong (HK) | 2025-02-19 | — | — | EP | claimed |
| CN-119125384-A | Method for determining concentration of Mo Nuola-pyrrosid and/or active metabolite beta-d-N4-hydroxycytosine in human body fluid based on liquid chromatography-mass spectrometry after chemical derivatization of benzoyl chloride | 中国人民解放军海军军医大学第一附属医院 | 2024-12-13 | — | — | CN | claimed |
| CN-118086264-A | Cytidine deaminase immobilization based on T4 phage-bound magnetic bead composite material | 江苏海洋大学 | 2024-05-28 | — | — | CN | claimed |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2024-05-02 | — | — | US | claimed |
| CN-117881403-A | Thionucleosides as antiviral agents | 爱莫里大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117858710-A | Method for treating veterinary viral diseases | 英特维特国际股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117858711-A | Nucleoside and nucleotide analogs as antiviral agents | 爱莫里大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117512078-A | Single primer to double primer amplicon conversion | 西格马-奥尔德里奇有限责任公司 | 2024-02-06 | — | — | CN | claimed |
| WO-2018057846-A1 | SINGLE PRIMER TO DUAL PRIMER AMPLICON SWITCHING | SIGMA-ALDRICH CO, LLC (US) | 2018-03-29 | — | — | WO | claimed |
| CN-107427529-A | N4-hydroxycytidine and derivatives and antiviral uses related thereto | 埃莫里大学 | 2017-12-01 | — | — | CN | claimed |
| US-20160333340-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | Twist Bioscience Corporation | 2016-11-17 | — | — | US | claimed |
| WO-2016183100-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | Twist Bioscience Corporation (US) | 2016-11-17 | — | — | WO | claimed |
| WO-2008033432-A2 | IMMUNE MODULATION BY CHEMICALLY MODIFIED RIBONUCLEOSIDES AND OLIGORIBONUCLEOTIDES | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-03-20 | — | — | WO | claimed |
| US-5817799-A | 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-10-06 | — | — | US | claimed |
| EP-0540686-B1 | 2'-FLUOROFURANOSYL DERIVATIVES AND NOVEL METHOD OF PREPARING 2'-FLUOROPYRIMIDINE AND 2'-FLUOROPURINE NUCLEOSIDES | US COMMERCE (US) | 1995-08-30 | — | — | EP | claimed |
| EP-0540686-A4 | 2'-FLUOROFURANOSYL DERIVATIVES AND NOVEL METHOD OF PREPARING 2'-FLUOROPYRIMIDINE AND 2'-FLUOROPURINE NUCLEOSIDES | US COMMERCE (US) | 1993-05-26 | — | — | EP | claimed |
| EP-0540686-A1 | 2'-FLUOROFURANOSYL DERIVATIVES AND NOVEL METHOD OF PREPARING 2'-FLUOROPYRIMIDINE AND 2'-FLUOROPURINE NUCLEOSIDES. | US COMMERCE (US) | 1993-05-12 | — | — | EP | claimed |
| WO-1992001700-A1 | 2'-FLUOROFURANOSYL DERIVATIVES AND NOVEL METHOD OF PREPARING 2'-FLUOROPYRIMIDINE AND 2'-FLUOROPURINE NUCLEOSIDES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1992-02-06 | — | — | WO | claimed |